Skip to main content
. Author manuscript; available in PMC: 2024 Mar 14.
Published in final edited form as: Expert Opin Ther Targets. 2023 Dec 29;28(1-2):9–15. doi: 10.1080/14728222.2023.2298358

Table 1.

Small molecule inhibitors of LonP1.

Drug IC50 Mechanism of Action Reference
Bortezomib 17 nM Proteolytic active site inhibitor [6]
CDDO 13 μM Allosteric ATPase inhibitor [34]
CDDO-Me 1.9 μM Allosteric ATPase inhibitor [34]
CDDO-Im 2 μM Allosteric ATPase inhibitor [34]
Compound 141 0.059 μM Proteolytic active site inhibitor2 [37]
Coumarinic derivatives 4–8 nd Proteolytic active site inhibitor [38]
MG262 122 nM Proteolytic active site inhibitor [33]
Obtusilactone A 34.1 μM Proteolytic active site inhibitor2 [39]
Sesamin 19.9 μM Proteolytic active site inhibitor2 [39]
1

Boronic acid-based non-peptide inhibitor

2

Suggested by computational modelling

nd – Not determined